SCHEMBL31361810

SCHEMBL31361810

CCC(O)c1cc([N+](=O)[O-])c(C)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDE2A O00408 1/20 0.41
CYP3A4 P08684 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 3/20 0.36
RECQL P46063 1/20 0.36
GPR35 Q9HC97 2/20 0.35
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ADRB2 P07550 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27859137 0.77 TSHR (0.41) ALDH1A1MAPTSMN1; SMN2CYP3A4TSHR
SCHEMBL29525219 0.74 ALDH1A1 (0.53) ALDH1A1MAPTSMN1; SMN2CYP3A4CYP1A2
SCHEMBL440478 0.74 ALDH1A1 (0.53) ALDH1A1MAPTSMN1; SMN2CYP3A4CYP1A2
SCHEMBL27859136 0.74 ALDH1A1 (0.39) ALDH1A1MAPTSMN1; SMN2CYP3A4CYP1A2
SCHEMBL397387 0.73 ATM (0.50) ALDH1A1MAPTSMN1; SMN2CYP3A4CYP1A2
SCHEMBL2471756 0.73 ALDH1A1 (0.47) ALDH1A1MAPTSMN1; SMN2CYP3A4CYP1A2
SCHEMBL23153879 0.72 ALDH1A1 (0.46) ALDH1A1MAPTSMN1; SMN2CYP3A4CYP2C19
SCHEMBL22897917 0.72 TSHR (0.53) ALDH1A1MAPTCYP3A4CYP1A2CYP2C9
SCHEMBL12348008 0.72 GRM8 (0.49) ALDH1A1MAPTSMN1; SMN2CYP3A4TSHR
SCHEMBL10342981 0.72 GPR35 (0.47) ALDH1A1MAPTSMN1; SMN2CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119183452-A LRRK2 inhibitors 布雷宁疗法公司 2024-12-24 CN disclosed